Connor J. Gillis

Development of a rocking bioreactor strategy to augment pro-angiogenic factor secretion by human adipose-derived stromal cells

Cell therapies involving human adipose-derived stromal cells (hASCs) have shown promise for a range of clinical applications due to their ability to stimulate angiogenesis and dampen inflammation via paracrine mechanisms. However, a major barrier to the successful clinical translation of hASC-based therapies is that st...